Original Article
Predictors of Underlying Esophageal Motility Disorders in Patients Presenting with Esophageal Candidiasis
Abstract
Objectives: Esophageal motility disorders (EMDs) are a known risk factor for esophageal candidiasis (EC), but this relation has not been described particularly well. We sought to evaluate the predictors of underlying EMDs in patients presenting with EC.Methods: Cases of EC at a single medical center between 2010 and 2021 were identified retrospectively based on the International Classification of Diseases, Ninth Revision code. Demographic, clinical, endoscopic, and manometric data were reviewed. The diagnosis of EC was based on typical endoscopic appearance.
Results: In total, 130 EC patients were identified (mean age 69.5 ± 14.6; 66.2% male). Of these, 12 (9.2%) had an underlying EMD (11 cases of achalasia; 1 case of esophagogastric junction outflow obstruction). Five (41.7%) of these patients had previously been diagnosed as having an EMD, whereas 7 were newly diagnosed only after their presentation with EC. No significant differences were noted between those with or without EMDs in terms of demographics, medical comorbidities, or medication use. Patients with an EMD, however, were more likely to complain of dysphagia (91.7% vs 30.5%, P < 0.001), and on endoscopy, they were more likely to have residual food in the esophagus, residual fluid in the esophagus, a dilated esophagus, and resistance to traversing the esophagogastric junction (all P < 0.001). Sixty-one (46.9%) patients with EC died during follow-up (mean 58 months).
Conclusions: EMDs are present in approximately 10% of patients presenting with EC, with half being diagnosed only after presenting with EC. Similar to non-EC patients, patients with EC with dysphagia and the typical endoscopic findings of achalasia are more likely to have an EMD and warrant prompt manometric evaluation.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Mohamed AA, Lu XL, Mounmin FA. Diagnosis and treatment of esophageal candidiasis: current updates. Can J Gastroenterol Hepatol 2019;2019:3585136.
2. Takahashi Y, Nagata N, Shimbo T, et al. Long-term trends in esophageal candidiasis prevalence and associated risk factors with or without HIV infection: lessons from an endoscopic study of 80,219 patients. PLoS One 2015;10:e0133589.
3. Choi JH, Lee CG, Lim YJ, et al. Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea. Yonsei Med J 2013;54:160–165.
4. Yakoob J, Jafri W, Abid S, et al. Candida esophagitis: risk factors in non-HIV population in Pakistan. World J Gastroenterol 2003;9:2328–2331.
5. Weerasuriya N, Snape J. A study of candida esophagitis in elderly patients attending a district general hospital in the UK. Dis Esophagus 2006;19:189–192.
6. Chocarro Martínez A, Galindo Tobal F, Ruiz-Irastorza G, et al. Risk factors for esophageal candidiasis. Eur J Clin Microbiol Infect Dis 2000;19:96–100.
7. Mushi MF, Ngeta N, Mirambo MM, et al. Predictors of esophageal candidiasis among patients attending endoscopy unit in a tertiary hospital, Tanzania: a retrospective cross-sectional study. Afr Health Sci 2018;18:66–71.
8. Ogiso H, Adachi S, Mabuchi M, et al. Risk factors for the development of esophageal candidiasis among patients in community hospital. Sci Rep 2021;11:20663.
9. Weerasuriya N, Snape J. Oesophageal candidiasis in elderly patients: risk factors, prevention and management. Drugs Aging 2008;25:119–130.
10. Zhan SK, Wu XQ, Zheng FP. Clinical characteristics and manifestations of fungal esophagitis: a single-center experience in south China. Gastroenterol Res Pract 2021;2021:8869494.
11. Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA 2015;313: 1841–1852.
12. Kumar P, Mohan S, Verma A, et al. Candida esophagitis in achalasia cardia: case report and review of literature. Saudi J Gastroenterol 2007;13:88–90.
13. Hendel L, Svejgaard E, Walsøe I, et al. Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole. Scand J Gastroenterol 1988;23:1182–1186.
14. Hoversten P, Otaki F, Katzka DA. Course of esophageal candidiasis and outcomes of patients at a single center. Clin Gastroenterol Hepatol 2019;17:200–202.e1.
15. Levine MS, Macones AJ Jr, Laufer I. Candida esophagitis: accuracy of radiographic diagnosis. Radiology 1985;154:581–587.
16. Kodsi BE, Wickremesinghe C, Kozinn PJ, et al. Candida esophagitis: a prospective study of 27 cases. Gastroenterology 1976;71:715–719.
17. Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil 2021;33:e14058.
18. Howard PJ, Maher L, Pryde A, et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 1992;33:1011–1015.
19. Ho KY, Tay HH, Kang JY. A prospective study of the clinical features, manometric findings, incidence and prevalence of achalasia in Singapore. J Gastroenterol Hepatol 1999;14:791–795.
20. Tebaibia A, Boudjella MA, Boutarene D, et al. Incidence, clinical features and para-clinical findings of achalasia in Algeria: experience of 25 years. World J Gastroenterol 2016;22:8615–8623.
21. Akaishi T, Nakano T, Machida T, et al. Clinical usefulness of endoscopy, barium fluoroscopy, and chest computed tomography for the correct diagnosis of achalasia. Intern Med 2020;59:323–328.
